Company / Return on Assets (ROA)
Caris Life Sciences, Inc. Return on Assets (ROA) History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-6.0%
FY2025
5-year range
-6.0% / -6.0%
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#118 of 158
Health Care
What the data says
Caris Life Sciences, Inc.'s return on assets (roa) of -6.0% is lower than 75% of companies in the Health Care sector (FY2025).
Based on SEC 10-K filings.
-6.0% in FY2025.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 158This company -6.0% Sector average -2.3%
▼
-163.7% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -6.0% | - |
| FY2024 | - | - |
| FY2023 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026